SEC Form 4 · accession 0001645627-18-000036
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jun 29, 2018
Accepted (ET)
Jul 6, 2018 · 6:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 29, 2018 | P | 1,000 | $0.0364 | A | 25,169,289 | D | |
| Common Stock | Jun 29, 2018 | P | 1,000 | $0.0359 | A | 25,170,289 | D | |
| Common Stock | Jul 2, 2018 | P | 1,000 | $0.035 | A | 25,171,289 | D | |
| Common Stock | Jul 2, 2018 | P | 1,000 | $0.0348 | A | 25,172,289 | D | |
| Common Stock | Jul 2, 2018 | P | 1,000 | $0.0348 | A | 25,173,289 | D | |
| Common Stock | Jul 5, 2018 | P | 1,000 | $0.0338 | A | 25,174,289 | D |
Table II — derivative securities
No Table II lines on this filing.